In the OVCAR8 cell-derived xenograft model, mice treated with these two 1Ais exhibited a clear reduction in tumor size and weight without apparent toxicity, suggesting that targeting eIF1A with these small molecules has the potential to decrease ovarian tumor growth. The gene discussed is EIF1; the disease is ovarian neoplasm.